Table 1.
Clinical and biochemical characteristic of PCOS patients (n = 217) and normal controls (n = 144)
| Characteristics | PCOS patients (n = 217) | Controls (n = 144) |
|---|---|---|
| Age (y) | 32.47 ± 3.04 (29-35) | 33.09 ± 3.36 (29-36) |
| BMI (kg/m2) | 34.99 ± 5.84 (24.38-56.23) | 18.77 ± 2.13 (15.04-25.08) |
| Waist/hip ratio (WHR) | 1.23 ± 0.09 (1.00-2.24) | 0.72 ± 0.06 (0.63-0.82) |
| FSH (mIU/ml) | 8.75 ± 2.75 (1.50-29.98) | 5.93 ± 1.64 (2.71-12.22) |
| LH (mIU/ml) | 12.61 ± 9.87 (1.50-37.67) | 2.93 ± 1.34 (1.01-6.43) |
| E2 (pg/ml) | 64.69 ± 52.11 (7.53-133.36) | 29.4 ± 13.7 (3.84-58.05) |
| Prolactin (ng/ml) | 20.22 ± 14.52 (3.46-108.80) | 11.08 ± 5.86 (3.71-42.02) |
| TSH (μIU/ml) | 3.39 ± 2.15 (0.69-15.74) | 1.7 ± 0.85 (0.02-3.67) |
| DHEA-S (μg/dl) | 298.48 ± 115.34 (68.26-568.41) |
142.96 ± 50.22 (60.86-233.11) |
| Testosterone (ng/ml) | 0.87 ± 0.31 (0.09-1.29) | 0.22 ± 0.13 (0.01-0.48) |
Numerical data were presented as means ± standard deviation (SD). Abbreviations: BMI, Body mass index: WHR, Waist-hip ratio: FSH, Follicle-stimulating hormone: LH, Luteinizing hormone: E2, Estradiol: TSH, Thyroid-stimulating hormone; DHEA-S, Dehydroepiandrosterone-sulfate